vs
Alkermes plc.（ALKS）与Rackspace Technology, Inc.（RXT）财务数据对比。点击上方公司名可切换其他公司
Rackspace Technology, Inc.的季度营收约是Alkermes plc.的1.8倍（$682.8M vs $384.5M），Alkermes plc.净利率更高（12.8% vs -4.8%，领先17.6%），Rackspace Technology, Inc.同比增速更快（-0.4% vs -10.6%），Alkermes plc.自由现金流更多（$170.0M vs $56.0M），过去两年Alkermes plc.的营收复合增速更高（4.8% vs -0.6%）
Alkermes plc是一家全产业链布局的生物制药企业，专注于精神障碍与神经系统疾病相关药物的研发。公司1987年由迈克尔·沃尔创立，2011年9月与原Élan集团旗下的药物制剂及生产部门Elan Drug Technologies合并，总部位于都柏林，在马萨诸塞州沃尔瑟姆设有研发中心，俄亥俄州威尔明顿建有生产基地。
Rackspace Technology, Inc.是总部位于美国得克萨斯州圣安东尼奥的云计算企业，在弗吉尼亚州雷斯顿以及澳大利亚、加拿大、英国、印度、迪拜、瑞士、荷兰、德国、新加坡、墨西哥、中国香港等多个国家和地区设有办事处，数据中心分布于全球多个主要城市，为客户提供专业的云计算相关服务。
ALKS vs RXT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $384.5M | $682.8M |
| 净利润 | $49.3M | $-32.7M |
| 毛利率 | 88.0% | 17.6% |
| 营业利润率 | 15.1% | -0.5% |
| 净利率 | 12.8% | -4.8% |
| 营收同比 | -10.6% | -0.4% |
| 净利润同比 | -66.3% | 41.6% |
| 每股收益（稀释后） | $0.29 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $384.5M | $682.8M | ||
| Q3 25 | $394.2M | $671.2M | ||
| Q2 25 | $390.7M | $666.3M | ||
| Q1 25 | $306.5M | $665.4M | ||
| Q4 24 | $430.0M | $685.6M | ||
| Q3 24 | $378.1M | $675.8M | ||
| Q2 24 | $399.1M | $684.9M | ||
| Q1 24 | $350.4M | $690.8M |
| Q4 25 | $49.3M | $-32.7M | ||
| Q3 25 | $82.8M | $-67.1M | ||
| Q2 25 | $87.1M | $-54.5M | ||
| Q1 25 | $22.5M | $-71.5M | ||
| Q4 24 | $146.5M | $-56.0M | ||
| Q3 24 | $92.4M | $-186.6M | ||
| Q2 24 | $91.4M | $25.0M | ||
| Q1 24 | $36.8M | $-640.6M |
| Q4 25 | 88.0% | 17.6% | ||
| Q3 25 | 86.9% | 19.4% | ||
| Q2 25 | 87.3% | 19.4% | ||
| Q1 25 | 83.9% | 19.1% | ||
| Q4 24 | 85.6% | 19.2% | ||
| Q3 24 | 83.3% | 20.3% | ||
| Q2 24 | 84.6% | 19.2% | ||
| Q1 24 | 83.3% | 19.2% |
| Q4 25 | 15.1% | -0.5% | ||
| Q3 25 | 22.6% | -5.1% | ||
| Q2 25 | 23.8% | -3.8% | ||
| Q1 25 | 4.5% | -5.8% | ||
| Q4 24 | 37.8% | -4.2% | ||
| Q3 24 | 27.7% | -25.7% | ||
| Q2 24 | 27.5% | -7.9% | ||
| Q1 24 | 12.4% | -94.5% |
| Q4 25 | 12.8% | -4.8% | ||
| Q3 25 | 21.0% | -10.0% | ||
| Q2 25 | 22.3% | -8.2% | ||
| Q1 25 | 7.3% | -10.7% | ||
| Q4 24 | 34.1% | -8.2% | ||
| Q3 24 | 24.4% | -27.6% | ||
| Q2 24 | 22.9% | 3.7% | ||
| Q1 24 | 10.5% | -92.7% |
| Q4 25 | $0.29 | $-0.13 | ||
| Q3 25 | $0.49 | $-0.28 | ||
| Q2 25 | $0.52 | $-0.23 | ||
| Q1 25 | $0.13 | $-0.31 | ||
| Q4 24 | $0.88 | $-0.20 | ||
| Q3 24 | $0.55 | $-0.82 | ||
| Q2 24 | $0.53 | $0.11 | ||
| Q1 24 | $0.21 | $-2.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $388.6M | $105.8M |
| 总债务越低越好 | — | $2.7B |
| 股东权益账面价值 | $1.8B | $-1.2B |
| 总资产 | $2.5B | $2.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $388.6M | $105.8M | ||
| Q3 25 | $616.4M | $99.5M | ||
| Q2 25 | $521.2M | $103.9M | ||
| Q1 25 | $399.8M | $128.0M | ||
| Q4 24 | $291.1M | $144.0M | ||
| Q3 24 | $396.3M | $157.1M | ||
| Q2 24 | $535.1M | $190.2M | ||
| Q1 24 | $420.8M | $282.6M |
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.9B | ||
| Q1 24 | — | $3.0B |
| Q4 25 | $1.8B | $-1.2B | ||
| Q3 25 | $1.7B | $-1.2B | ||
| Q2 25 | $1.6B | $-1.1B | ||
| Q1 25 | $1.5B | $-1.1B | ||
| Q4 24 | $1.5B | $-1.0B | ||
| Q3 24 | $1.3B | $-949.7M | ||
| Q2 24 | $1.3B | $-756.2M | ||
| Q1 24 | $1.3B | $-787.2M |
| Q4 25 | $2.5B | $2.8B | ||
| Q3 25 | $2.3B | $2.8B | ||
| Q2 25 | $2.3B | $2.9B | ||
| Q1 25 | $2.1B | $3.0B | ||
| Q4 24 | $2.1B | $3.1B | ||
| Q3 24 | $2.2B | $3.1B | ||
| Q2 24 | $2.2B | $3.4B | ||
| Q1 24 | $2.1B | $3.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $170.1M | $59.7M |
| 自由现金流经营现金流 - 资本支出 | $170.0M | $56.0M |
| 自由现金流率自由现金流/营收 | 44.2% | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.45× | — |
| 过去12个月自由现金流最近4个季度 | $480.3M | $90.6M |
8季度趋势，按日历期对齐
| Q4 25 | $170.1M | $59.7M | ||
| Q3 25 | $101.7M | $70.7M | ||
| Q2 25 | $150.2M | $8.4M | ||
| Q1 25 | $98.8M | $12.6M | ||
| Q4 24 | $190.4M | $54.3M | ||
| Q3 24 | $81.6M | $51.8M | ||
| Q2 24 | $146.0M | $24.1M | ||
| Q1 24 | $21.1M | $-90.3M |
| Q4 25 | $170.0M | $56.0M | ||
| Q3 25 | $84.4M | $42.7M | ||
| Q2 25 | $137.2M | $-12.4M | ||
| Q1 25 | $88.7M | $4.3M | ||
| Q4 24 | $180.6M | $34.4M | ||
| Q3 24 | $73.3M | $27.3M | ||
| Q2 24 | $138.9M | $-14.5M | ||
| Q1 24 | $12.8M | $-118.4M |
| Q4 25 | 44.2% | 8.2% | ||
| Q3 25 | 21.4% | 6.4% | ||
| Q2 25 | 35.1% | -1.9% | ||
| Q1 25 | 28.9% | 0.6% | ||
| Q4 24 | 42.0% | 5.0% | ||
| Q3 24 | 19.4% | 4.0% | ||
| Q2 24 | 34.8% | -2.1% | ||
| Q1 24 | 3.6% | -17.1% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 4.4% | 4.2% | ||
| Q2 25 | 3.3% | 3.1% | ||
| Q1 25 | 3.3% | 1.2% | ||
| Q4 24 | 2.3% | 2.9% | ||
| Q3 24 | 2.2% | 3.6% | ||
| Q2 24 | 1.8% | 5.6% | ||
| Q1 24 | 2.4% | 4.1% |
| Q4 25 | 3.45× | — | ||
| Q3 25 | 1.23× | — | ||
| Q2 25 | 1.72× | — | ||
| Q1 25 | 4.40× | — | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 1.60× | 0.96× | ||
| Q1 24 | 0.57× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALKS
| Vivitrol | $124.1M | 32% |
| Aristada And Aristada Initio | $97.2M | 25% |
| LYBALVI | $94.1M | 24% |
| Royalty | $65.7M | 17% |
| Manufacturing Revenue | $3.3M | 1% |
RXT
| Public Cloud Services Segment | $442.2M | 65% |
| Private Cloud Service Segment | $240.6M | 35% |
